MEDIUM confidence: 100% data completeness, but the composite (38) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $18.4B— | $20.6B+11.8% | $24.4B+18.5% | $30.3B+24.1% | $34.5B+14.1% |
| EPS (dil.) | $-1.08— | $-0.05n/m | $0.75n/m | $0.08-88.8% | $0.11+30.5% |
| Free Cash Flow | -$1.1B— | -$259Mn/m | $1.8Bn/m | $1.0B-42.7% | $522M-48.2% |
| Gross Margin | 16.0% | 22.9%+6.9pp | 25.4%+2.5pp | 29.2%+3.8pp | 29.4%+0.2pp |
| Operating Margin | -8.1% | -0.5%+7.6pp | 1.9%+2.5pp | 1.4%-0.5pp | 1.4%-0.1pp |
| Net Margin | -8.4% | -0.4%+7.9pp | 5.6%+6.0pp | 0.5%-5.1pp | 0.6%+0.1pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $25 (last qtr, 7 analysts) → $23 (last mo, 4) (-8.7%).
Buy-rated share 74% → 72% over ~3 months (-1pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $-0.27 | $-0.32 | -19.0% |
| May 2026 | $-0.09 | $-0.15 | -60.7% |
| Feb 2026 | $0.03 | $-0.01 | -134.5% |
| Nov 2025 | $0.04 | $0.05 | +36.5% |
| Aug 2025 | $0.07 | $0.02 | -69.7% |
| May 2025 | $0.05 | $0.06 | +12.2% |
| Feb 2025 | $0.01 | $0.04 | +300.0% |
| Nov 2024 | $0.01 | $0.06 | +400.0% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider $133.4M over 180 days (3 open-market buys, 2 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 8.6%/yr (revenue basis).
Base free cash flow $1.1B (avg FY2023–FY2025; latest year $522M) · equity value $28.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 38 for CPNG indicates a neutral outlook, driven by a mix of factors. The stock scores high on growth, with revenue and EPS growth of 14.1% and 28.2%, respectively, but is dragged down by its value and profitability scores, due to a high P/E and negative ROE of -18.8%. The long-term and short-term scores are relatively aligned, with only a 2-point difference, suggesting a consistent view across different time horizons. CPNG's momentum score is also subdued, reflecting a 12-month return of -42.8% and a bearish moving average trend.